Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05250570 · ClinicalTrials.gov registry record · NA
Distress Tolerance for Benzodiazepine Discontinuation
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05250570: Clinical Trial NA study, sponsored by University of Pittsburgh.
NCT05250570 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05250570, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The proposed study is a clinical trial, designed to pilot test a Distress Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist therapy (OAT) who currently use benzodiazepines versus a Relaxation Therapy (RT) control condition. The DT-BD intervention is an adjunctive psychosocial intervention in people seeking to discontinue (BZD) use.
Primary Outcome
Number of participants with BZD discontinuation defined by no BZD use by self-report during the month prior to 4-month follow-up corroborated by urine testing.
Interventions
- BEHAVIORAL Relaxation Therapy
- BEHAVIORAL Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2022-12-09 |
| Phase | NA |
Why NCT05250570 stopped before completion
NCT05250570 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Relaxation Therapy is the first listed.
NCT05250570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05250570 about?
NCT05250570 is a clinical study titled "Distress Tolerance for Benzodiazepine Discontinuation". The proposed study is a clinical trial, designed to pilot test a Distress Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist therapy (OAT) who currently use benzodiazepines versus a Relaxation Therapy (RT) control condition. The DT-BD intervention is an adju...
What is the current status of trial NCT05250570?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-06-17. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT05250570?
The interventions under investigation include: Relaxation Therapy (BEHAVIORAL), Distress Tolerance - Benzodiazepine Discontinuation (DT-BD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05250570?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05250570's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI